Is Generate Biomedicines, Inc. (GENB) a Buy, Sell, or Hold?
NASDAQ : GENB
Generate Biomedicines, Inc. — Analyst Ratings
$14 USD
-$0.03 (-0.21%)
- Volume
- 314.67K
- Average Volume
- 815.76K
- Market Capitalization
- $1.79B
- P/E Ratio
- -2.81
- Dividend Yield
- 0.00%
- Price Target
- $23.50
- Year High
- $18.18
- Year Low
- $11.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.85
Analyst Consensus Summary
Consensus Rating
Sell
2 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-40.4%
vs Current Price
Price Target
$23.50
Average TargetPrice Target Range
Lowest Target
$22.00
-36.4% DOWNSIDE
Average Target
$23.50
Median Estimate
Highest Target
$25.00
-44.0% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 2
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 2 | 0 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Morgan Stanley | Sean Laaman | $22 | $16.11 | 2026-05-14 08:11 AM | 36.6% |
| H.C. Wainwright | Mitchell Kapoor | $25 | $13.585 | 2026-05-08 06:28 AM | 84.0% |